124 related articles for article (PubMed ID: 35093475)
1. Finger printing human norovirus-like particles by capillary isoelectric focusing with whole column imaging detection.
Du J; Wu G; Cui C; Yu C; Cui Y; Guo L; Liu Y; Liu Y; Wang W; Liu C; Fu Z; Li M; Guo S; Yu X; Yang Y; Duan M; Xu G; Wang L
Virus Res; 2022 Apr; 311():198700. PubMed ID: 35093475
[TBL] [Abstract][Full Text] [Related]
2. Isoelectric point determination of norovirus virus-like particles by capillary isoelectric focusing with whole column imaging detection.
Goodridge L; Goodridge C; Wu J; Griffiths M; Pawliszyn J
Anal Chem; 2004 Jan; 76(1):48-52. PubMed ID: 14697031
[TBL] [Abstract][Full Text] [Related]
3. Chimeric virus-like particles of human norovirus constructed by structure-guided epitope grafting elicit cross-reactive immunity against both GI.1 and GII.4 genotypes.
Hou YN; Jin YQ; Zhang XF; Tang F; Hou JW; Liu ZM; Han ZB; Zhang H; Du LF; Shao S; Su JG; Liang Y; Zhang J; Li QM
J Virol; 2023 Oct; 97(10):e0093823. PubMed ID: 37792003
[TBL] [Abstract][Full Text] [Related]
4. Biological and physico-chemical characterization of human norovirus-like particles under various environmental conditions.
Abou-Hamad N; Estienney M; Chassagnon R; Bon M; Daval-Frerot P; de Rougemont A; Guyot S; Bouyer F; Belliot G
Colloids Surf B Biointerfaces; 2023 Nov; 231():113545. PubMed ID: 37741147
[TBL] [Abstract][Full Text] [Related]
5. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
[TBL] [Abstract][Full Text] [Related]
6. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
Huo Y; Wan X; Ling T; Shen S
Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
[TBL] [Abstract][Full Text] [Related]
7. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity.
Hu L; Salmen W; Chen R; Zhou Y; Neill F; Crowe JE; Atmar RL; Estes MK; Prasad BVV
Nat Commun; 2022 Mar; 13(1):1241. PubMed ID: 35273142
[TBL] [Abstract][Full Text] [Related]
8. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
Devant JM; Hofhaus G; Bhella D; Hansman GS
Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
[TBL] [Abstract][Full Text] [Related]
9. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
[TBL] [Abstract][Full Text] [Related]
10. A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody production and T cell responses.
Kim NE; Kim MJ; Park BJ; Kwon JW; Lee JM; Park JH; Song YJ
Vaccine; 2024 Feb; 42(6):1392-1400. PubMed ID: 38320930
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
Malm M; Vesikari T; Blazevic V
Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
[TBL] [Abstract][Full Text] [Related]
12. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
13. Sequence addition to the N- or C-terminus of the major capsid protein VP1 of norovirus affects its cleavage and assembly into virus-like particles.
Ma J; Liu J; Zheng L; Wang C; Zhao Q; Huo Y
Microb Pathog; 2022 Aug; 169():105633. PubMed ID: 35700875
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
Huo Y; Zheng L; Chen X; Ge L; Wang Y
Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
[TBL] [Abstract][Full Text] [Related]
15. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human papillomavirus by capillary isoelectric focusing with whole-column imaging detection.
Zhou CM
Electrophoresis; 2013 Nov; 34(20-21):3046-53. PubMed ID: 23925949
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
18. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.
Ma Y; Li J
J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
Chen W; Kang T; Yuan R; Shao C; Jing S
Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
[TBL] [Abstract][Full Text] [Related]
20. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
